FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KAMENCIC, H.
Right arrow Articles by JUURLINK, B. H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KAMENCIC, H.
Right arrow Articles by JUURLINK, B. H. J.
(The FASEB Journal. 2001;15:243-250.)
© 2001 FASEB

Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function

HUSE KAMENCIC*, ROBERT W. GRIEBEL{dagger}, ANDREW W. LYON{ddagger}, PHYLLIS G. PATERSON§ and BERNHARD H. J. JUURLINK*1

Departments of
* Anatomy and Cell Biology,
{dagger} Surgery (Neurosurgery),
{ddagger} Pathology, and
§ College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada

1Correspondence: Department of Anatomy and Cell Biology, 107 Wiggins Road, University of Saskatchewan, Saskatoon, SK, S7N 5E5, Canada. E-mail: juurlink{at}duke.usask.ca


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
The study aimed to 1) quantify oxidative stress in spinal cord after crush injury at T6, 2) determine whether the administration of the procysteine compound L-2-oxothiazolidine-4-carboxylate (OTC) would up-regulate glutathione (GSH) synthesis and decrease oxidative stress, and 3) determine whether decreased oxidative stress results in better tissue and function retention. We demonstrate that spinal cord compression (5 s with a 50 g aneurysm clip) at T6 in rats results in oxidative stress that is extensive (significant increases in oxidative stress seen at C3 and L4) and rapid in onset. Indices of oxidative stress used were GSH content, protein carbonyl content, and inactivation of glutathione reductase. Administration of OTC resulted in a marked decrease in oxidative stress associated with a sparing of white matter at T6 (16±1.9% retained in OTC-treated animals vs. less than 1% in saline-treated). Behavioral indices in control, saline-treated, and OTC-treated animals after 6 wk were respectively: angle board scores (59°, 32°, and 42°), modified Tarlov score (7, 2.4, and 4.1), and Basso-Beattie-Bresnahan score (21, 5.3, and 12.9). We conclude that administration of OTC after spinal cord trauma greatly decreases oxidative stress and allows tissue preservation, thereby enabling otherwise paraplegic animals to locomote.—Kamencic, H., Griebel, R. W., Lyon, A. W., Paterson, P. G., Juurlink, B. H. J. Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function.


Key Words: central nervous system • functional recovery • neurotrauma • oxidative stress • paraplegia


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
SPINAL CORD TRAUMA often leads to paraplegia and quadriplegia, imposing a great burden on the individual afflicted as well as family, friends, and society at large. Although various experimental treatments have been tried, the only clinically proven treatment now available for spinal cord trauma is the administration of methylprednisolone (1 , 2) . One primary mechanism of action of methylprednisolone is thought to be the scavenging of lipid peroxyl radicals, which inhibits the lipid peroxidation cascade (3 , 4) . Inhibiting oxidative stress should inhibit activation of nuclear factor kappa B (NF{kappa}B) (5) , thereby inhibiting activation of proinflammatory gene expression. Indeed, methylprednisolone does inhibit inflammatory responses after spinal cord injury (6) . However, the improvement seen with methylprednisolone treatment is modest (7) and may be associated with adverse side effects (8) .

Oxidative stress, particularly lipid peroxidation cascades, and associated inflammation are major secondary mechanisms whereby physical trauma results in spinal cord injury (9 10 11 12) . Minimizing oxidative stress should decrease post-traumatic inflammation since oxidative stress activates proinflammatory mechanisms (5) . The quenching of lipid peroxyl radicals, thought to be a major mechanism of action by methylprednisolone (3 , 4) , is only a small part of the cell’s total antioxidant defense mechanisms (12 , 13) . Since the tripeptide glutathione (GSH) plays many roles in the minimization of oxidative stress, we reasoned that promotion of GSH synthesis would be an effective way to decrease post-traumatic oxidative stress and thereby promote retention of tissue integrity and function after spinal cord trauma. GSH is involved in the scavenging of both inorganic and organic peroxides, the sources of strong oxidants; scavenging of 4-hydroxyalkenals, strong oxidants derived from lipid peroxides; scavenging of {alpha}-oxo-aldehydes, strong oxidants that are increased under conditions of oxidative stress; and the regeneration of vitamin E from the vitamin E radical (reviewed in refs 5 , 13 ).

GSH is synthesized in a two-step process, with the first reaction being the ligation of glutamate with cysteine forming L-{gamma}-glutamyl-cysteine and the second step being the ligation of glycine to L-{gamma}-glutamyl-cysteine, thereby forming GSH. The first step is rate-limiting, with cysteine being the rate-limiting amino acid (14) . Two compounds that have been used to increase intracellular cysteine are N-acetylcysteine and L-2-oxothiazolidine-4-carboxylate (OTC). N-acetylcysteine does not cross the blood–brain barrier (15) whereas OTC does (16) , and it has been shown to increase brain cysteine (16) and GSH (17) contents. Furthermore, an in vitro model of spinal cord injury has demonstrated that OTC but not N-acetylcysteine could increase neuronal GSH and increase survival (18) .

The objectives of the experiments described in this article were to test the hypothesis that increasing spinal cord GSH content by the administration of OTC after spinal cord injury would be an efficacious way to reduce oxidative stress and thereby minimize tissue damage and maximize functional retention. We demonstrate that the data collected after administration of OTC after spinal cord trauma support our hypothesis.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Surgical procedures
Adult male Wistar rats (~320 g) were obtained from Charles River Canada and housed in a temperature-regulated animal facility, exposed to a 12 h light/dark cycle and with free access to food and water. Animals were treated in accordance with the guidelines of the Canadian Council on Animal Care. Before surgery, the rats received the analgesic buprenorphine-hydrochloride (Reckitt Colman Ltd.) subcutaneously (s.c.) at a dose of 0.05 mg/kg and then every 12 h for the first 72 h after surgery. Anesthesia was performed with halothane (5% induction and 1% maintenance). Laminectomy was performed aseptically at T5-T6 to expose the spinal cord. A 5 s clip compression injury was induced at the T6 spinal cord level using a modified Kerr-Lougheed aneurysm clip (Walsh Manufacturing, Oakville, Ontario) with a calibrated force of 50 g as described previously (19 , 20) . For delivery of drug or vehicle, a sterile catheter was placed s.c. running from the dorsum to enter the peritoneal cavity ventrally; this was done before the laminectomy was performed. Thirty minutes after spinal cord compression, OTC (Sigma, St. Louis, Mo.) or saline vehicle was delivered intraperitoneally and then every 12 h for the next 5 days. The initial dose of OTC was 12 mmol/kg body weight with maintenance doses of 4 mmol/kg body weight. Animals were closely observed for behavior, eating, and drinking as well as weight loss for the first 12 h and thereafter at a minimum of three times daily. Manual bladder expressions were performed three times daily.

Measurements of oxidative stress
A total of 54 animals was used to determine the onset of oxidative stress after spinal cord injury. We used GSH level, protein carbonyl content and glutathione reductase activity as markers of oxidative stress with spinal cord tissue isolated at 1 h, 3 h, 6 h, 24 h, and 48 h after injury. Rats were transcardially perfused with cold saline, vertebral columns were cooled with liquid nitrogen, and the after spinal cord segments were isolated: C3, T3, T5, T6, T7, T9, and L4. Spinal cord segments were frozen in liquid nitrogen and stored at -80°C until analyzed.

GSH was measured using 5,5'-dithio-bis(2-nitrobenzoic) acid-derivatization [DTNB], followed by high-performance liquid chromatography (HPLC) and UV detection (21) . Briefly, tissues were homogenized in 5% sulfosalicylic acid containing 0.2 mM EDTA and sonicated (3x5 s, with intermittent cooling). The homogenates were centrifuged at 10,000 g for 15 min and supernatants were collected, derivatized, and analyzed using the Shimadzu reversed-phase HPLC with ultraviolet detection. We used a final concentration of 3500 nmol DTNB per reaction for a total volume of 1 ml. Data were collected digitally with Shimadzu Ezchrom Version 3.2 chromatography software. GSH content in rat spinal segments was expressed in mol/g wet weight.

Protein carbonyl content was determined spectrophotometrically using 2,4-dinitrophenylhydrazine (DNPH) to trap carbonyls with the adduct formed measured at 360 nm (22) . Results are expressed as pmol of DNPH incorporated per mg of protein calculated using a molar absorption coefficient of 22,000 M-1 cm-1 for aliphatic hydrazones.

Glutathione reductase was calculated by measuring the disappearance of NADPH (Sigma) in the presence of oxidized-glutathione based on the procedure described by Eklow et al. (23) , as we have done previously (24) .

Measurement of functional recovery
For behavioral studies, 39 animals were randomly assigned to one of three groups: 1) animals that had no surgery (5 animals); 2) animals with surgery and spinal cord compression that received OTC (17 animals); and 3) animals that received surgery and spinal cord compression that received the saline vehicle only (17 animals). One of the saline-treated and four of the OTC-treated animals were killed because of bladder complications. One saline- and one OTC-treated animal were each killed because of complications arising from the surgery.

Three behavioral tests were used: the angle board method (25) , a modified Tarlov score (26) , and the Basso-Beattie-Bresnahan (BBB) open field locomotor rating scale (27) . The inclined plane is a behavioral task that assesses the animal’s ability to maintain its position on a rubber corrugated board; this board was raised at 5° increments. The maximum angle at which an animal can support its weight for 5 s is the capacity angle.

A semiquantitative assessment of hind limb function during open field walking was performed using the Tarlov scale as modified by Tariq and colleagues (26) . Spontaneous activity of hind limb was scored as follows: 0 = total paraplegia of hind limbs; 1 = no spontaneous movements but responds to hind limb pinch; 2 = spontaneous movement; 3 = able to support weight but unable to walk; 4 = walks with gross deficit; 5 = walks with mild deficit on broad flat surface, 6 = able to walk on broad flat surface and support weight on a 1.8 cm wide ledge; 7 = walks on a ledge.

Procedures for the open field training and testing of the BBB score as described in Basso et al. (27) were acquired only part way through the study; hence, BBB testing was done on only 11 saline-treated and 7 OTC-treated animals. The scale has 22 levels that range from 0 (= total paralysis) to 21 (= normal locomotion). Briefly, rats were gentled and adapted to the open field during the fifth week postsurgery and animals were tested at 6 wk The final open field tests were videotaped for some rats.

Spinal cord histomorphometry
After 6 wk of behavioral evaluation, the spinal cords were fixed by transcardial perfusion with 0.03 M phosphate-buffered saline (pH 7.4) containing 1% sodium nitrite in rats anesthetized with halothane, followed by perfusion (100 ml/100 g) with either 4% formaldehyde (freshly prepared from paraformaldehyde) or FAM solution (formaldehyde, acetic acid, and methanol in 1:1:8 ratio) and left in the same fixative for 5 days. Spinal cord segments were isolated from each animal, embedded in paraffin, cut into 15 µm thick sections, stained for myelin with Luxol fast blue, and counterstained with cresyl violet. Spinal cord tissue staining deep blue was interpreted as being intact white matter. Area of white matter was quantified using Northern Eclipse software and expressed in pixels.

Chemicals
All chemicals used for the analytical procedures were obtained from Sigma.

Statistics
Data are expressed as means ± SE. Where SEMs are not visible, they are smaller than the symbols. Statistical analyses were performed with the program InStat.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Spinal cord trauma resulted in a rapid and extensive onset of oxidative stress as determined by GSH measurements (Fig. 1 ). At T6, the site of injury, GSH content was reduced to less than half of the normal within 1 h, with immediately adjacent segments having almost as large a drop in GSH. Over the next 48 h there were further decreases in spinal cord GSH, with sites as distant as C3 and L4 experiencing significant decreases. Laminectomy without spinal cord crush caused a small (10%) drop in GSH at T6 but had no effect on other levels of the spinal cord (results not presented). The large decrease in GSH at the site of injury and adjacent segments was correlated with a significant decrease in activity of glutathione reductase 24 h post-trauma in spinal cord segments T3 to T9 (Fig. 2 ). Protein carbonyls were significantly increased in spinal cord levels T3-T9 examined 24 h after injury; the site of injury and immediately adjacent segments experienced the greatest increase in protein carbonyls (Fig. 3 ).



View larger version (35K):
[in this window]
[in a new window]
 
Figure 1. Spinal cord GSH levels in control nontraumatized animals and in traumatized animals at different times post-trauma. Data are means ± SE (n=3). Within 1 h GSH has dropped significantly at T5 (P<0.001), T6 (P<0.001), T7 (P<0.001), and T9 (P<0.05). By 48 h GSH has significantly dropped at C3 (P<0.01), T3 (P<0.05), T9 (P<0.001), and L4 (P<0.001). One-factor ANOVA with post hoc Bonferrroni test, with time as the dependent variable.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 2. Spinal cord glutathione reductase activity under control conditions and 24 h after spinal cord injury with either saline vehicle or OTC treatment. Data are means ± SE (n=3). Spinal cord injury with saline vehicle treatment caused a significant decrease in glutathione reductase activity at T3 (P<0.05), T5 (P<0.01), T6 (P<0.001), T7 (P<0.001), and T9 (P<0.001). Treatment with OTC significantly inhibited the decrease in glutathione reductase activity at T5 (P<0.05), T6 (P<0.01), T7 (P<0.01), and T9 (P<0.01). One-tailed Student’s t test.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 3. Spinal cord protein carbonyl content under control and 24 h post-trauma in saline- and OTC-treated animals. Data are means ± SE (n=3). Using a one-tailed Student’s t test, spinal cord trauma caused a significant increase in protein carbonyl at T3 (P<0.01), T5 (P<0.001), T6 (P<0.001), T7 (P<0.001), T9 (P<0.001), and L4 (P<0.001), while addition of OTC significantly decreased protein carbonyl formation at T5 (P<0.05), T6 (P<0.01), T7 (P<0.01), and T9 (P<0.05).

Animals weighed 328.3 ± 4.2 g prior to surgery. The weight of saline-treated animals 6 wk after surgery increased to 403.9 ± 9.5 g while the weight gain of OTC-treated animals was significantly greater (P=0.0337, two-tailed Student’s t test) at 434.3 ± 9.3 g.

Administration of OTC after injury increased spinal cord GSH (Fig. 4 ) and resulted in higher glutathione reductase activity (Fig. 2) and decreased protein carbonyl content (Fig. 3) compared to animals given the saline vehicle.



View larger version (40K):
[in this window]
[in a new window]
 
Figure 4. Spinal cord GSH content 26 h after injury and 2 h after OTC administration comparing saline vehicle treatment with OTC treatment. Data are means ± SE (n=3). A Wilcoxon spinal cord segment paired nonparametric two-tailed test indicated that spinal cord GSH levels were significantly different (P=0.0033) in the OTC-treated vs. the saline-treated group of rats.

Six weeks after spinal cord crush in saline-treated animals, much of the T6 spinal cord was occupied by a large cystic cavity with no gray matter evident and less than 1% of white matter remaining (Fig. 5 ). Administration of OTC did not result in gray matter sparing at T6, but a peripheral rim of white matter was observed at T6 in all spinal cords examined from animals that were administered OTC (Fig. 5) . The amount of white matter retained varied from 10.5 to 26% of the control value (Fig. 6 ).



View larger version (140K):
[in this window]
[in a new window]
 
Figure 5. Photomicrographs of T6 spinal cords stained with cresyl violet and Luxol fast blue. Dorsal is at the top. A) Control spinal cord with dorsal and ventral roots evident below dura mater. The remaining spinal cords were fixed 6 wk after spinal cord trauma. B) Typical example of a spinal cord from a saline-treated animal with a BBB score of 4. Much of T6 spinal cord is cystic. Although myelinated dorsal and ventral roots are evident, there is little spinal cord Luxol fast blue-positive central myelin. C) Spinal cord from an OTC-treated animal with a BBB score of 11. Although cystic, a thin rim of myelinated axons is evident in the spinal cord. Arrow indicates a region with substantial amount of white matter retained. D) Spinal cord from an OTC-treated animal with a BBB score of 14. A larger proportion of myelinated axons is retained in this spinal cord.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 6. Graph depicting area of white matter in pixels at mid-T6 spinal cord segment in control as well as saline-treated and OTC-treated animals that underwent spinal cord crush at T6. Data represent means ± SE (n=3). OTC-treated animals have significantly more Luxol fast blue-stained material than saline-treated animals (P<0.05, two-tailed Welch’s t test).

Spinal cord trauma caused a decrease in angle board capacity angle from 59° to 28° (Fig. 7 ); during the 6 wk recovery in saline-treated animals this increased to 32° whereas in OTC-treated animals this increased to 42° (Fig. 7) . Trauma decreased the Tarlov score from 7 to 1 (Fig. 8A ). Over the next 6 wk, saline-treated animals increased their Tarlov score to 2.4 whereas OTC-treated animals increased to 4.1. BBB scores for 6 wk recovery are given in Fig. 8B . The behavior of 5 animals that underwent laminectomy without spinal cord crush was examined after 1 wk. The Tarlov score was 6.93 ± 0.06 in these animals, which was not significantly different from the 7.0 before the laminectomy, and capacity angle was 57.2 ± 1.0, which was not significantly different from the 58.2 ± 0.3 prior to the laminectomy.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 7. Angle board scores (means±SE) of animals prior to and after spinal cord crush in animals treated with saline vehicle (n=15) and OTC (n=12). Using ANOVA and post hoc Bonferroni test, the capacity angles between saline treated and OTC treated are significantly different from 1 wk onward (P<0.01).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 8. Behavioral scores of animals before and after spinal cord injury. A) Tarlov scores between saline (n=15) and OTC-treated (n=12) animals are significantly different from 1 wk onward (P<0.001: one-way ANOVA with a post hoc Bonferroni test). B) BBB scores of the same animals at 6 wk after injury. OTC-treated animals (n=7) have a significantly better BBB score than saline-treated animals (n=11) (P<0.0001, two-tailed Student’s t test).


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Model
The model of spinal cord trauma in this study, first described by Rivlin and Tator (19) , was chosen because it has been demonstrated to give consistent results (20) . The damage caused by the 50 g force aneurysm clip is severe and resulted in permanent paraplegia with little recovery of hind limb function, as has been described previously (20) . This is in keeping with the histological picture showing cystic T6 spinal cord segment with almost no white matter remaining. Trauma caused loss of bladder control, but after 3 wk both saline-treated and OTC-treated animals regained bladder control. More OTC-treated animals (four animals) were lost due to bladder problems than saline-treated animals (one animal). This was correlated with regain of skeletal muscle function, which enabled animals to actively resist bladder expression; hence, we do not believe this was a direct adverse effect of OTC, but yet another indicator of better recovery in the OTC-treated animals.

Oxidative stress
Three criteria indicated that spinal cord trauma resulted in severe oxidative stress being experienced by the tissue directly traumatized as well as segments immediately adjacent to the traumatized T6 segment. These were decreases in tissue GSH, decreases in tissue glutathione reductase activity, and increases in protein carbonyl content. These criteria were chosen for the following reasons: 1) oxidative stress consumes GSH either by oxidation or through formation of adducts with electrophilic compounds (5 , 13) ; 2) protein carbonyls are formed after exposure to a variety of oxidants (28 29 30) and thus serves as a good overall index of oxidative stress experienced by a tissue; and 3) glutathione reductase is enzymatically inactivated by a number of oxidants (31 32 33) and, thus, affords an effective functional index of tissue oxidative stress.

Within 1 h there were significant decreases in GSH in spinal segments T5 to T9, with the greatest decrease seen at the site of injury and immediately adjacent segments. Over the next 2 days, and particularly between 24 and 48 h, GSH levels were significantly decreased not only from T5-T9, but also throughout the spinal cord from spinal segments C3 to L4. This may be due to the oxidative stress that accompanies the prominent inflammatory changes seen after spinal cord trauma (34 35 36 37) . Other laboratories have shown that within less than 1 h of spinal cord trauma there is activation of NF{kappa}B, which persists for at least 72 h (34) , and by 24 h there is massive neutrophil infiltration and the presence of large numbers of activated microglia/macrophages at the site of injury as well as adjacent sites (35) . Our preliminary observations (not presented) also demonstrate marked inflammatory changes at 24 h postinjury. The role of these inflammatory leukocytes in secondary injury is indicated by the significantly increased retention of function after spinal cord trauma if neutrophils (36) or macrophages (37) are depleted. That oxidative stress is also severe at the site of injury and immediately adjacent segments is supported by the significant decrease in activity of glutathione reductase in the spinal cord segments T3 to T9 and by the increase in protein carbonyl content 24 h after spinal cord crush.

The GSH that disappeared from the tissue could not be recovered as oxidized glutathione (GSSG). Preliminary experiments using sodium borohydride to reduce glutathiyl-protein adducts from injured spinal cord suggest that GSSG produced formed glutathiyl-protein adducts. This agrees with other studies demonstrating that glutathiyl-protein adducts are formed during oxidative stress (38 39 40) . Such adducts cannot be reduced by glutathione reductase; hence, de novo synthesis of GSH becomes critical in the tissue’s antioxidant mechanisms. De novo synthesis of GSH is what administration of OTC facilitates. Work in other laboratories has demonstrated that tissue cysteine levels peak 4 h after administration of OTC (16) . This suggests that GSH levels should peak ~4 h after administration of OTC. In an environment where there is oxidative stress, GSH is being consumed due to antioxidant activities; therefore, rises in GSH after administration of OTC would be expected to be limited. Nevertheless, we found measurable increases in spinal cord GSH in OTC-treated animals relative to saline-treated controls; these GSH increases were associated with an overall decrease in oxidative stress experienced by the spinal cords as determined by measuring glutathione reductase activities and protein carbonyl contents. We conclude that administration of OTC significantly reduced oxidative stress after spinal cord trauma.

Tissue and functional sparing
The decrease in oxidative stress after OTC administration was associated with sparing of white matter at T6 as indicated by Luxol fast blue staining. Luxol fast blue is a classical myelin stain. Six weeks after injury the stained myelin will be associated with intact axons. Hence, Luxol fast blue staining is an indirect measure of intact axons, with cross-sectional area of staining being correlated with total number of intact axons. The validity of measuring Luxol fast blue-stained spinal cord as a measure of intact white matter is indicated by the positive correlation between this measure and the functional scores. However, additional studies are required that involve counts of retrogradely and anterogradely labeled neurons similar to that performed by Fehlings and Tator (41) . In the animals measured, the average amount of white matter spared was between 10.5 and 26% in comparison to less than 1% in the saline-treated animals. Although this is a modest amount, the crush insult was severe. No gray matter was retained at T6; this is similar to the earlier findings of Khan and Griebel (20) . Sparing of white matter allowed significant functional recovery with animals attaining BBB scores ranging from 11 to 14 in comparison to a score of 5.3 with saline-treated animals. Previous research by Fehlings and Tator has demonstrated that as little as 12% of axons retained after injury allows considerable locomotory function as determined by measuring inclined plane capacity angles (41) .

Significance
There are several possible approaches for therapeutic intervention after spinal cord injury. One approach is to try to repair the damage, for example, by promoting axon regeneration (42) or through introduction of embryonic stem cells that differentiate and possibly re-establish some of the disrupted circuitry (43) ; these are technically challenging approaches.

A second approach is to minimize secondary mechanisms of tissue damage after spinal cord injury. Prevention of damage is a much more efficacious treatment of spinal cord injury than to attempt repair once damage has occurred. Other than the very modest sparing effect of methylprednisolone, so far there is no effective way of diminishing secondary damage after spinal cord injury. The findings with methylprednisolone indicate that minimizing oxidative stress can have beneficial therapeutic consequences. Since there are many pathways that cause oxidative stress and methylprednisolone acts on only a few of these pathways, any intervention that can act on more than one pathway has the potential to be highly effective in minimizing oxidative stress after a perturbation. As outlined at the beginning of this article, GSH is involved with many pathways that minimize oxidative stress. The promotion of de novo GSH synthesis is especially critical since the glutathione that becomes oxidized after spinal cord trauma forms glutathiyl-protein adducts and, thus, is no longer available to be reduced back to GSH. In principle, therefore promoting GSH synthesis should be an effective way to minimize oxidative stress and thus minimize secondary damage. Indeed, this is what we find.

In summary, we demonstrate that administration of the cysteine prodrug L-2-oxothiazolidine-4-carboxylate, which has shown few adverse effects in numerous small human clinical trials (44 45 46) , can effectively minimize oxidative stress and tissue damage after spinal cord trauma, resulting in significant retention of function. Our data suggest that promoting GSH synthesis may be an effective therapeutic approach for treating spinal cord injury in humans. In the research described in this paper we have examined only one dosing regimen, based on the data presented in Anderson and Meister (16) and Mesina et al. (17) , and a therapeutic intervention starting at only one time point after injury. We have not yet examined for any interactions with methylprednisolone, the only approved intervention after spinal cord injury in humans. It is clear that before clinical trials can begin, a dose response study must be performed, the therapeutic window identified, and whether there are synergistic or antagonistic interactions with methylprednisolone must be determined. Some of these studies are under way, and preliminary data indicate that significant therapeutic effects are seen with doses as low as 1 mmol/kg body weight.


   ACKNOWLEDGMENTS
 
The ideas that led to this research project arose from research that was funded by the Medical Research Council of Canada (# MT 13467 to B.H.J.J.). This specific project was funded by the Neurotrauma Initiative, Saskatchewan. H.K. holds a Health Services Utilization and Research Commission (Saskatchewan) Post-Doctoral Fellowship. We thank Angela Damant, Arlene Drimmie, and Michelle Moroz for their excellent technical assistance. Finally, we wish to thank Drs. Brenda Cross and Ernie Olfert for offering advice on the postsurgical maintenance of the animals.

Received for publication April 11, 2000. Revision received July 7, 2000.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Bracken, M. B., Shepard, M. J., Holford, T. R., Leo-Summers, L., Aldrich, E. F., Fazl, M., Fehlings, M., Herr, D. L., Hitchon, P. W., Marshall, L. F., Nockels, R. P., Pascale, V., Perot, P. L., Jr, Piepmeier, J., Sonntag, V. K., Wagner, F., Wilberger, J. E., Winn, H. R., Young, W. (1997) Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. J. Am. Med. Assoc. 277,1597-1604[Abstract]
  2. Bracken, M. B., Shepard, M. J., Holford, T. R., Leo-Summers, L., Aldrich, E. F., Fazl, M., Fehlings, M. G., Herr, D. L., Hitchon, P. W., Marshall, L. F., Nockels, R. P., Pascale, V., Perot, P. L., Jr, Piepmeier, J., Sonntag, V. K., Wagner, F., Wilberger, J. E., Winn, H. R., Young, W. (1998) Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J. Neurosurg. 89,699-706[Medline]
  3. Hall, E. D. (1992) The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76,13-22[Medline]
  4. Koc, R. K., Akdemir, H., Karakucuk, E. I., Oktem, I. S., Menku, A. (1999) Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord 37,29-32[Medline]
  5. Christman, J. W., Blackwell, T. S., Juurlink, B. H. J. (2000) Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol 10,153-162[Medline]
  6. Bartholdi, D., Schwab, M. E. (1995) Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res 672,177-186[Medline]
  7. Nesathurai, S. (1998) Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J. Trauma 45,1088-1093[Medline]
  8. Galandiuk, S., Raque, G., Appel, S., Polk, H. C., Jr (1993) The two-edged sword of large-dose steroids for spinal cord trauma. Ann. Surg. 218,419-425[Medline]
  9. Brown, S. A., Hall, E. D. (1992) Role of oxygen-derived free radicals in the pathogenesis of shock and trauma, with focus on central nervous system injuries. J. Am. Vet. Med. Assoc. 200,1849-1859[Medline]
  10. Anderson, D. K., Hall, E. D. (1993) Pathophysiology of spinal cord trauma. Ann. Emerg. Med. 22,987-992[Medline]
  11. Springer, J. E., Azbill, R. D., Mark, R. J., Begley, J. G., Waeg, G., Mattson, M. P. (1997) 4-Hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J. Neurochem. 68,2469-2476[Medline]
  12. Juurlink, B. H. J., Paterson, P. G. (1998) Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J. Spinal Cord Med. 21,309-334[Medline]
  13. Juurlink, B. H. J. (1999) Management of oxidative stress in the CNS: the many roles of glutathione. Neurotox. Res. 1,119-140[Medline]
  14. Meister, A. (1989) Metabolism and function of glutathione. In Glutathione. Chemical, Biochemical, and Medical Aspects (Dolphin, D., Avramovic, O., and Poulson, R., eds) Vol. A, pp. 367–474, John Wiley & Sons, New York
  15. McLellan, L. I., Lewis, A. D., Hall, D. J., Ansell, J. D., Wolf, C. R. (1995) Uptake and distribution of N-acetylcysteine in mice: tissue-specific effects on glutathione concentrations. Carcinogenesis 16,2099-2106[Abstract/Free Full Text]
  16. Anderson, M. E., Meister, A. (1989) Marked increase of cysteine levels in many regions of the brain after administration of 2-oxothiazolidine-4-carboxylate. FASEB J 3,1632-1636[Abstract]
  17. Mesina, J. E., Page, R. H., Hetzel, F. W., Chopp, M. (1989) Administration of L-2-oxothiazolidine-4-carboxylate increases glutathione levels in rat brain. Brain Res 478,181-183[Medline]
  18. Lucas, J. H., Wheeler, D. G., Emery, D. G., Mallery, S. R. (1998) The endogenous antioxidant glutathione as a factor in the survival of physically injured mammalian spinal cord neurons. J. Neuropathol. Exp. Neurol. 57,937-954[Medline]
  19. Rivlin, A. S., Tator, C. H. (1979) Effect of duration of acute spinal cord compression in a new acute injury model in the rat. Surg. Neurol. 9,39-43
  20. Khan, M., Griebel, R. (1983) Acute spinal cord injury in the rat: comparison of three experimental techniques. Can. J. Neurol. Sci. 10,161-165[Medline]
  21. Komuro, C., Ono, K., Shibamoto, Y., Nishidai, T., Takahashi, M., Abe, M. (1985) Rapid and simple method for quantitative determination of non-protein sulphydryls in mouse liver by reversed-phase high-performance chromatography. J. Chromatogr. 338,209-212[Medline]
  22. Levine, R. L., Garland, D., Olivier, C. N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B., Shaltiel, S., Stadtman, E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186,464-478[Medline]
  23. Eklow, L., Moldeus, P., Orrenius, S. (1984) Oxidation of glutathione during hydroperoxide metabolism. Eur. J. Biochem. 138,459-463[Medline]
  24. Juurlink, B. H. J., Thorburne, S. K., Hertz, L. (1998) Peroxide scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia 22,371-378[Medline]
  25. Rivlin, A. S., Tator, C. H. (1977) Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47,577-581[Medline]
  26. Tariq, M., Morais, C., Kishore, P. N., Biary, N., Al Deeb, S., Al Moutaery, K. (1998) Neurological recovery in diabetic rats following spinal cord injury. J. Neurotrauma 15,239-251[Medline]
  27. Basso, D. M., Beattie, M. S., Breshnahan, J. C. (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12,1-21[Medline]
  28. Burcham, P. C., Kuhan, Y. T. (1996) Introduction of carbonyl groups into proteins by the lipid peroxidation product, malondialdehyde. Biochem. Biophys. Res. Commun. 220,996-1001[Medline]
  29. Blakeman, D. P., Ryan, T. P., Jolly, R. A., Petry, T. W. (1998) Protein oxidation: examination of potential lipid-independent mechanisms for protein carbonyl formation. J. Biochem. Mol. Toxicol. 12,185-190[Medline]
  30. Miyata, T., Inagi, R., Asahi, K., Yamada, Y., Horie, K., Sakai, H., Uchida, K., Kurokawa, K. (1998) Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. FEBS Lett 437,24-28[Medline]
  31. Blakytny, R., Harding, J. J. (1992) Glycation (non-enzymic glycosylation) inactivates glutathione reductase. Biochem. J. 288,303-307
  32. Tabatabaie, T., Floyd, R. A. (1994) Susceptibility of glutathione peroxidase and glutathione reductase to oxidative damage and the protective effect of spin trapping agents. Arch. Biochem. Biophys. 314,112-119[Medline]
  33. Barker, J. E., Heales, S. J., Cassidy, A., Bolanos, J. P., Land, J. M., Clark, J. B. (1996) Depletion of brain glutathione results in a decrease of glutathione reductase activity; an enzyme susceptible to oxidative damage. Brain Res 716,118-122[Medline]
  34. Bethea, J. R., Castro, M., Keane, R. W., Lee, T. T., Dietrich, W. D., Yezierski, R. P. (1998) Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18,3251-3260[Abstract/Free Full Text]
  35. Carlson, S. L., Parrish, M. E., Springer, J. E., Doty, K., Dossett, L. (1998) Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151,77-88[Medline]
  36. Taoka, Y., Okajima, K., Uchiba, M., Murakami, K., Kushimoto, S., Johno, M., Naruo, M., Okabe, H., Takatsuki, K. (1997) Role of neutrophils in spinal cord injury in the rat. Neuroscience 79,1177-1182[Medline]
  37. Popovich, P. G., Guan, Z., Wei, P., Huitinga, I., van Rooijen, N., Stokes, B. T. (1999) Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158,351-365[Medline]
  38. Bellomo, G., Mirabelli, F., DiMonte, D., Richelmi, P., Thor, H., Orrenius, C., Orrenius, S. (1987) Formation and reduction of glutathione-protein mixed disulfides during oxidative stress. A study with isolated hepatocytes and menadione (2-methyl-1,4-naphthoquinone). Biochem. Pharmacol. 36,1313-1320[Medline]
  39. Schuppe, I., Moldéus, P., Cotgreave, I. A. (1992) Protein-specific S-thiolation in human endothelial cells during oxidative stress. Biochem. Pharmacol. 44,1757-1764[Medline]
  40. Shivakumar, B. R., Kolluri, S. V., Ravindranath, V. (1995) Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia. J. Pharmacol. Exp. Ther. 274,1167-1173[Abstract/Free Full Text]
  41. Fehlings, M. G., Tator, C. H. (1995) The relationship among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 132,220-228[Medline]
  42. Huang, D. W., McKerracher, L., Braun, P. E., David, S. (1999) A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 24,639-647[Medline]
  43. McDonald, J. W., Liu, X. Z., Qu, Y., Liu, S., Mickey, S. K., Turetsky, D., Gottlieb, D. I., Choi, D. W. (1999) Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nature Med 5,1410-1412[Medline]
  44. Kalayjian, R. C., Skowron, G., Emgushov, R.-T., Chance, M., Spell, S. A., Borum, P. R., Webb, L. S., Mayer, K. H., Jackson, L. B., Yen-Lieberman, B., Story, K. O., Rowe, W. B., Thompson, K., Goldberg, D., Trimbo, S., Lederman, M. M. (1994) A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (Procysteine) in asymptomatic HIV-infected subjects. J. Acquir. Immune Defic. Syndr. 7,369-374
  45. Bernard, G. R., Wheeler, A. P., Arons, M. M., Morris, P. E., Paz, H. L., Russell, J. A., Wright, P. E. (1997) A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The antioxidant in ARDS Study Group. Chest 112,164-172[Abstract/Free Full Text]
  46. Vita, J. A., Frei, B., Holbrook, M., Gokce, N., Leaf, C., Keaney, J. F. (1998) L-2-oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J. Clin. Invest. 101,1408-1414[Medline]



This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
H. S. SHARMA
A Select Combination of Neurotrophins Enhances Neuroprotection and Functional Recovery following Spinal Cord Injury
Ann. N.Y. Acad. Sci., December 1, 2007; 1122(1): 95 - 111.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. D. Golding, S. T. R. MacDonald, B. H. J. Juurlink, and B. W. C. Rosser
The effect of glutamine on locomotor performance and skeletal muscle myosins following spinal cord injury in rats
J Appl Physiol, October 1, 2006; 101(4): 1045 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Sun, A. Y. Shih, H. C. Johannssen, H. Erb, P. Li, and T. H. Murphy
Two-photon Imaging of Glutathione Levels in Intact Brain Indicates Enhanced Redox Buffering in Developing Neurons and Cells at the Cerebrospinal Fluid and Blood-Brain Interface
J. Biol. Chem., June 23, 2006; 281(25): 17420 - 17431.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
H. S. SHARMA, R. D. BADGAIYAN, P. ALM, S MOHANTY, and L. WIKLUND
Neuroprotective Effects of Nitric Oxide Synthase Inhibitors in Spinal Cord Injury-Induced Pathophysiology and Motor Functions: An Experimental Study in the Rat
Ann. N.Y. Acad. Sci., August 1, 2005; 1053(1): 422 - 434.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Wu, M. H. Noyan Ashraf, M. Facci, R. Wang, P. G. Paterson, A. Ferrie, and B. H. J. Juurlink
Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system
PNAS, May 4, 2004; 101(18): 7094 - 7099.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KAMENCIC, H.
Right arrow Articles by JUURLINK, B. H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KAMENCIC, H.
Right arrow Articles by JUURLINK, B. H. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS